NR3C1 and neoplasm: C-terminal inhibitors of HSP90 such as novobiocin and the herbal compound silibinin could induce the release of mature GR in corticotroph tumor cellsin vitro, andin vivo silibinin was able to revert glucocorticoid resistance in a corticotroph tumor allograft mouse model, leading to a partial restoration of symptoms of the disease61.